Works by Sandner, Peter

Results: 54
    1
    2

    Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model.

    Published in:
    Aging Cell, 2022, v. 21, n. 9, p. 1, doi. 10.1111/acel.13683
    By:
    • Ataei Ataabadi, Ehsan;
    • Golshiri, Keivan;
    • Jüttner, Annika A.;
    • de Vries, René;
    • Van den Berg‐Garrelds, Ingrid;
    • Nagtzaam, Nicole M. A.;
    • Khan, Hina N.;
    • Leijten, Frank P. J.;
    • Brandt, Renata M. C.;
    • Dik, Willem A.;
    • van der Pluijm, Ingrid;
    • Danser, A. H. Jan;
    • Sandner, Peter;
    • Roks, Anton J. M.
    Publication type:
    Article
    3
    4
    5
    6

    Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.

    Published in:
    Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02189-1
    By:
    • Becker-Pelster, Eva M.;
    • Hahn, Michael G.;
    • Delbeck, Martina;
    • Dietz, Lisa;
    • Hüser, Jörg;
    • Kopf, Johannes;
    • Kraemer, Thomas;
    • Marquardt, Tobias;
    • Mondritzki, Thomas;
    • Nagelschmitz, Johannes;
    • Nikkho, Sylvia M.;
    • Pires, Philippe V.;
    • Tinel, Hanna;
    • Weimann, Gerrit;
    • Wunder, Frank;
    • Sandner, Peter;
    • Schuhmacher, Joachim;
    • Stasch, Johannes-Peter;
    • Truebel, Hubert K. F.
    Publication type:
    Article
    7
    8
    9
    10

    Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease.

    Published in:
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, v. 394, n. 12, p. 2363, doi. 10.1007/s00210-021-02149-4
    By:
    • Bénardeau, Agnès;
    • Kahnert, Antje;
    • Schomber, Tibor;
    • Meyer, Jutta;
    • Pavkovic, Mira;
    • Kretschmer, Axel;
    • Lawrenz, Bettina;
    • Hartmann, Elke;
    • Mathar, Ilka;
    • Hueser, Joerg;
    • Kraehling, Jan R.;
    • Eitner, Frank;
    • Hahn, Michael G.;
    • Stasch, Johannes-Peter;
    • Sandner, Peter
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.

    Published in:
    Nature Medicine, 2012, v. 18, n. 2, p. 252, doi. 10.1038/nm.2634
    By:
    • Jaumann, Mirko;
    • Dettling, Juliane;
    • Gubelt, Martin;
    • Zimmermann, Ulrike;
    • Gerling, Andrea;
    • Paquet-Durand, François;
    • Feil, Susanne;
    • Wolpert, Stephan;
    • Franz, Christoph;
    • Varakina, Ksenya;
    • Xiong, Hao;
    • Brandt, Niels;
    • Kuhn, Stephanie;
    • Geisler, Hyun-Soon;
    • Rohbock, Karin;
    • Ruth, Peter;
    • Schlossmann, Jens;
    • Hütter, Joachim;
    • Sandner, Peter;
    • Feil, Robert
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13226, doi. 10.3390/ijms241713226
    By:
    • Kraehling, Jan R.;
    • Benardeau, Agnes;
    • Schomber, Tibor;
    • Popp, Laura;
    • Vienenkoetter, Julia;
    • Ellinger-Ziegelbauer, Heidrun;
    • Pavkovic, Mira;
    • Hartmann, Elke;
    • Siudak, Krystyna;
    • Freyberger, Alexius;
    • Hagelschuer, Ina;
    • Mathar, Ilka;
    • Hueser, Joerg;
    • Hahn, Michael G.;
    • Geiss, Volker;
    • Eitner, Frank;
    • Sandner, Peter
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.

    Published in:
    Rheumatology, 2024, v. 63, n. 11, p. 3124, doi. 10.1093/rheumatology/keae150
    By:
    • Khanna, Dinesh;
    • Kramer, Frank;
    • Höfler, Josef;
    • Ghadessi, Mercedeh;
    • Sandner, Peter;
    • Allanore, Yannick;
    • Denton, Christopher P;
    • Kuwana, Masataka;
    • Matucci-Cerinic, Marco;
    • Pope, Janet E;
    • Atsumi, Tatsuya;
    • Bečvář, Radim;
    • Czirják, László;
    • Langhe, Ellen De;
    • Hachulla, Eric;
    • Ishii, Tomonori;
    • Ishikawa, Osamu;
    • Johnson, Sindhu R;
    • Riccieri, Valeria;
    • Schiopu, Elena
    Publication type:
    Article
    35

    Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.

    Published in:
    Frontiers in Physiology, 2020, v. 11, p. 1, doi. 10.3389/fphys.2020.00345
    By:
    • Kolijn, Detmar;
    • Kovács, Árpád;
    • Herwig, Melissa;
    • Lódi, Mária;
    • Sieme, Marcel;
    • Alhaj, Abdulatif;
    • Sandner, Peter;
    • Papp, Zoltán;
    • Reusch, Peter H.;
    • Haldenwang, Peter;
    • Falcão-Pires, Ines;
    • Linke, Wolfgang A.;
    • Jaquet, Kornelia;
    • Van Linthout, Sophie;
    • Mügge, Andreas;
    • Tschöpe, Carsten;
    • Hamdani, Nazha
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.

    Published in:
    American Journal of Respiratory Cell & Molecular Biology, 2018, v. 58, n. 5, p. 636, doi. 10.1165/rcmb.2017-0292OC
    By:
    • Potoka, Karin P.;
    • Wood, Katherine C.;
    • Baust, Jeffrey J.;
    • Bueno, Marta;
    • Hahn, Scott A.;
    • Vanderpool, Rebecca R.;
    • Bachman, Tim;
    • Mallampalli, Grace M.;
    • Osei-Hwedieh, David O.;
    • Schrott, Valerie;
    • Bin Sun;
    • Bullock, Grant C.;
    • Becker-Pelster, Eva-Maria;
    • Wittwer, Matthias;
    • Stampfuss, Jan;
    • Mathar, Ilka;
    • Stasch, Johannes-Peter;
    • Truebel, Hubert;
    • Sandner, Peter;
    • Mora, Ana L.
    Publication type:
    Article
    45
    46

    Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.

    Published in:
    BJU International, 2017, v. 119, n. 2, p. 325, doi. 10.1111/bju.13691
    By:
    • Uvin, Pieter;
    • Albersen, Maarten;
    • Bollen, Ine;
    • Falter, Maarten;
    • Weyne, Emmanuel;
    • Linsen, Loes;
    • Tinel, Hanna;
    • Sandner, Peter;
    • Bivalacqua, Trinity J.;
    • De Ridder, Dirk J. M. K.;
    • Van der Aa, Frank;
    • Brône, Bert;
    • Van Renterghem, Koenraad
    Publication type:
    Article
    47

    Soluble GC stimulators and activators: Past, present and future.

    Published in:
    British Journal of Pharmacology, 2024, v. 181, n. 21, p. 4130, doi. 10.1111/bph.15698
    By:
    • Sandner, Peter;
    • Follmann, Markus;
    • Becker‐Pelster, Eva;
    • Hahn, Michael G.;
    • Meier, Christian;
    • Freitas, Cecilia;
    • Roessig, Lothar;
    • Stasch, Johannes‐Peter
    Publication type:
    Article
    48

    Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY‐747 designed for the treatment of resistant hypertension.

    Published in:
    British Journal of Pharmacology, 2023, v. 180, n. 19, p. 2500, doi. 10.1111/bph.16142
    By:
    • Wunder, Frank;
    • Stasch, Johannes‐Peter;
    • Knorr, Andreas;
    • Mondritzki, Thomas;
    • Brockschnieder, Damian;
    • Becker‐Pelster, Eva‐Maria;
    • Sandner, Peter;
    • Tinel, Hanna;
    • Redlich, Gorden;
    • Hartung, Ingo V.;
    • Vakalopoulos, Alexandros;
    • Follmann, Markus
    Publication type:
    Article
    49
    50